ORCHARD THERAPEUTICS PLC Proceeds from Stock Options Exercised
ORCHARD THERAPEUTICS PLC reported Proceeds from Stock Options Exercised of $2.70 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2022-03-30
- ORCHARD THERAPEUTICS PLC proceeds from stock options exercised for the quarter ending 2020-03-31 was $1.44M, a 28660.00% increase year-over-year.
- ORCHARD THERAPEUTICS PLC proceeds from stock options exercised for the quarter ending 2019-12-31 was $259.00K, a 25800.00% increase year-over-year.
- ORCHARD THERAPEUTICS PLC proceeds from stock options exercised for the quarter ending 2019-09-30 was $471.00K, a 23450.00% increase year-over-year.
- ORCHARD THERAPEUTICS PLC proceeds from stock options exercised for the quarter ending 2019-06-30 was $1.26M.
- ORCHARD THERAPEUTICS PLC proceeds from stock options exercised for fiscal 2021 was $2.70M, a 30.77% decline from fiscal 2020.
- ORCHARD THERAPEUTICS PLC proceeds from stock options exercised for fiscal 2020 was $3.90M, a 95.00% increase from fiscal 2019.
- ORCHARD THERAPEUTICS PLC proceeds from stock options exercised for fiscal 2019 was $2.00M.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-12-31 | $2.70M 10-K · filed 2022-03-30 | |||
| 2020-12-31 | $3.90M 10-K · filed 2022-03-30 | |||
| 2020-03-31 | $1.44M 10-Q · filed 2020-05-07 | $1.70M derived: sum of 2 quarters · filed 2021-03-02 | $2.17M derived: sum of 3 quarters · filed 2021-03-02 | $3.43M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-12-31 | $259.00K derived: 10-K 12 month − 6-K 9 month · filed 2021-03-02 | $730.00K derived: sum of 2 quarters · filed 2021-03-02 | $2.00M derived: sum of 3 quarters · filed 2021-03-02 | $2.00M 10-K · filed 2021-03-02 |
| 2019-09-30 | $471.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-11-07 | $1.74M derived: sum of 2 quarters · filed 2019-11-07 | $1.74M 6-K · filed 2019-11-07 | $1.74M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-06-30 | $1.26M derived: 6-K 6 month − 10-Q 3 month · filed 2019-08-08 | $1.27M 6-K · filed 2019-08-08 | $1.27M derived: sum of 3 quarters · filed 2020-05-07 | $1.27M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-03-31 | $5.00K 10-Q · filed 2020-05-07 | $6.00K derived: sum of 2 quarters · filed 2020-05-07 | $8.00K derived: sum of 3 quarters · filed 2020-05-07 | |
| 2018-12-31 | $1.00K derived: 20-F 12 month − 6-K 9 month · filed 2019-03-22 | $3.00K derived: sum of 2 quarters · filed 2019-11-07 | $28.00K 20-F · filed 2019-03-22 | |
| 2018-09-30 | $2.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-11-07 | $27.00K 6-K · filed 2019-11-07 | ||
| 2018-06-30 | $25.00K 6-K · filed 2019-08-08 |